Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients

Archivum Immunologiae et Therapiae Experimentalis

Volumn 57, Issue 4, 2009, Pages 291-294

  Szkaradkiewicz, Andrzej ^a   Marciniak, Ryszard ^a   Chudzicka Strugała, Izabela ^a   Wasilewska, Agnieszka ^a   Drews, Michał ^a   Majewski, Przemysław ^a   Karpiński, Tomasz ^a   Zwoździak, Barbara ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Colorectal cancer; Crohn's disease; Cytokines; Inflammation; Ulcerative colitis

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; STEROID;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MACROPHAGE; MALE; MONOCYTE; ULCERATIVE COLITIS; ADOLESCENT; BLOOD; CANCER STAGING; COLORECTAL TUMOR; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; RISK FACTOR;

ADOLESCENT; ADULT; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; CROHN DISEASE; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-10; MACROPHAGES; MALE; MIDDLE AGED; NEOPLASM STAGING; RISK FACTORS; STEROIDS;

EID: 70349252262     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-009-0031-z     Document Type: Article

References (28)

1. J Askling PW Dickman P Karlen, et al. 2001 Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study Lancet 357 262 266 11214128 10.1016/S0140-6736(00) 03612-6 1:STN:280:DC%2BD3M7islWlsw%3D%3D (Pubitemid 32120857)
2. F Autschbach T Giese N Gassler, et al. 2002 Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn's disease Virchows Arch 441 500 513 12447682 10.1007/s00428-002-0684-z 1:CAS:528:DC%2BD3sXos1eltA%3D%3D (Pubitemid 35430467)
3. C Belluco D Nitti M Frantz, et al. 2000 Interleukin-6 blood levels is associated with circulating carcinoembryonic antigen and prognosis in patients with colorectal cancer Ann Surg Oncol 7 133 138 10761792 10.1007/s10434-000- 0133-7 1:STN:280:DC%2BD3c3it1Chuw%3D%3D
4. WR Best JM Becktel JW Singleton, et al. 1976 Development of a Crohn's disease activity index Gastroenterology 70 439 444 1248701 1:STN:280: DyaE287hvVGmtg%3D%3D
5. TJ Bull EJ McMinn K Sidi-Boumedine, et al. 2003 Detection and verification of Mycobacterium avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn's disease J Clin Microbiol 41 2915 2923 12843021 10.1128/JCM.41.7.2915-2923.2003 1:CAS:528:DC%2BD3sXmsVWms7o%3D (Pubitemid 36842279)
6. JA Eaden KR Abrams JF Mayberry 2001 The risk of colorectal cancer in ulcerative colitis: a meta-analysis Gut 48 526 535 11247898 10.1136/gut.48.4.526 1:STN:280:DC%2BD3M3hs1Orsw%3D%3D (Pubitemid 32234798)
7. S Fujino A Andoh S Bamba, et al. 2003 Increased expression of interleukin 17 in inflammatory bowel disease Gut 52 65 70 12477762 10.1136/gut.52.1.65 1:CAS:528:DC%2BD3sXmtVyqsw%3D%3D (Pubitemid 36020767)
8. IJ Fuss F Heller M Boirivant, et al. 2004 Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis J Clin Invest 113 1490 1497 15146247 1:CAS:528:DC%2BD2cXktlClt70%3D
9. G Galizia M Orditura C Romano, et al. 2002 Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery Clin Immunol 102 169 178 11846459 10.1006/clim.2001.5163 1:CAS:528:DC%2BD38XisFWmtLk%3D (Pubitemid 34171516)
10. K Geboes R Riddell A Öst, et al. 2000 A reproducible grading scale for histological assessment of inflammation in ulcerative colitis Gut 47 404 409 10940279 10.1136/gut.47.3.404 1:STN:280:DC%2BD3cvjs1GitQ%3D%3D (Pubitemid 30670836)
11. H Groux A O'Garra M Bigler, et al. 1997 A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis Nature 389 737 742 9338786 10.1038/39614 1:CAS:528:DyaK2sXmvVSgtb0%3D (Pubitemid 27458961)
12. JG Hyun L Mayer 2006 Mechanisms underlying inflammatory bowel disease Drug Discov Today Dis Mech 3 457 462 10.1016/j.ddmec.2006.11.010 (Pubitemid 46268650)
13. T Jess M Gamborg P Matzen, et al. 2005 Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population- based cohort studies Am J Gastroenterol 100 2724 2729 16393226 10.1111/j.1572-0241.2005.00287.x (Pubitemid 43919641)
14. J Kamińska MM Kowalska MP Nowacki, et al. 2000 CRP, TNF-a, IL-1ra, IL-6, IL-8 and IL-10 in blood serum of colorectal cancer patients Pathol Oncol Res 6 38 41 10749586
15. MC Li SH He 2004 IL-10 and its related cytokines for treatment of inflammatory bowel disease World J Gastroenterol 10 620 625 14991925 1:CAS:528:DC%2BD2cXjtFGrsb0%3D
16. R Medzhitov CA Janeway 1997 Innate immunity: impact on the adaptive immune response Curr Opin Immunol 9 4 9 9039775 10.1016/S0952-7915(97)80152-5 1:CAS:528:DyaK2sXhsl2hurs%3D (Pubitemid 27095892)
17. TR Mosmann S Sad 1996 The expanding universe of T-cell subsets: Th1, Th2 and more Immunol Today 17 138 146 8820272 10.1016/0167-5699(96)80606-2 1:CAS:528:DyaK28XhsVensLo%3D (Pubitemid 26074503)
18. JJ Oppenheim R Neta 1994 Pathophysiological roles of cytokines in development, immunity and inflammation FASEB J 8 158 162 8119486 1:STN:280:DyaK2c7msVChtQ%3D%3D
19. S Pestka CD Krause D Sarkar, et al. 2004 Interleukin-10 and related cytokines and receptors Annu Rev Immunol 22 929 979 15032600 10.1146/annurev.immunol.22.012703.104622 1:CAS:528:DC%2BD2cXktlOgsbg%3D (Pubitemid 38680445)
20. SE Plevy CJ Landers J Prehn 1997 A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease J Immunol 159 6276 6282 9550432 1:CAS:528:DyaK1cXht1Whsw%3D%3D
21. DM Rennick MM Fort 2000 Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10-/-) mice and intestinal inflammation Am J Physiol Gastrointest Liver Physiol 278 G829 833 10859210 1:CAS:528: DC%2BD3cXks1Kntbw%3D
22. G Rogler T Andus 1998 Cytokines in inflammatory bowel disease World J Surg 22 382 389 9523521 10.1007/s002689900401 1:STN:280:DyaK1c7osVWhsA%3D%3D (Pubitemid 28113526)
23. RB Sartor 2004 Therapeutic manipulation of the enteric microflora in inflammatory bowel disease: antibiotics, probiotics, and prebiotics Gastroenterology 126 1620 1633 15168372 10.1053/j.gastro.2004.03.024 (Pubitemid 38649878)
24. DQ Shih SR Targan 2008 Immunopathogenesis of inflammatory bowel disease World J Gastroenterol 14 390 400 18200661 10.3748/wjg.14.390 1:CAS:528:DC%2BD1cXjvFKkt7Y%3D (Pubitemid 351320847)
25. A Szkaradkiewicz I Chudzicka-Strugala B Zwozdziak 2007 Mycobacterium avium subsp. paratuberculosis in inflammatory bowel diseases Przegl Epidemiol 61 85 90 17702444
26. A Taylor J Verhagen K Blaser, et al. 2006 Mechanisms of immune suppression by interleukin-10 and transforming growth factor-β the role of T regulatory cells Immunology 117 433 442 16556256 10.1111/j.1365-2567.2006. 02321.x 1:CAS:528:DC%2BD28XjsVGks70%3D
27. A Wiercińska-Drapało R Flisiak D Prokopowicz 2001 Effect of ulcerative colitis activity on plasma concentration of transforming growth factor beta1 Cytokine 14 343 346 11497495 10.1006/cyto.2001.0901 (Pubitemid 32730475)
28. D Yen J Cheung H Scheerens, et al. 2006 IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL- 17 and IL-6 J Clin Invest 116 1310 1316 16670770 10.1172/JCI21404 1:CAS:528:DC%2BD28XksVWns78%3D